학술논문
A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389), a potent, oral histamine H-4 receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults
Document Type
Journal
Author
Werfel, T.; Lynch, V; Asher, A.; Tsianakas, A.; Gupta, B.; Sarmiento, R.; Ploszczuk, A.; Kuna, P.; Majorek-Olechowska, B.; Cimoszko, B.; Nikkels, A.; Hofman, T.; Staubach, P.; Breuer, K.; Gawlik, A.; Buczylko, K.; Morren, M-A; Layton, G.; Yeadon, M.; Whitlock, L.; Purkins, L.; Liu, W.; Osterloh, I; Jimenez, P.
Source
Subject
Language
English
ISSN
13989995